InSingulo AB

📍 Mölndal, Sweden👥 13 employees💰 Last funded Oct 2019
Biotechnology🌐 insingulo.com
Website LinkedIn
At InSingulo, we specialize in the characterization of drug interactions with complex targets down to the single molecule level. Our biosensing technology allows for drug profiling on membrane proteins embedded in their native environment. We enable drug screening programs against membrane proteins and other challenging therapeutic targets.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Other investors· 2
Gisela. Sitbon
Gisela. Sitbon
Board Chair & Director
Board Member
7 investments
Oct 2019
?
Member of the board of In Singulo AB
Sep 2019
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in InSingulo AB?
InSingulo AB has 2 investors on record on gritt.io.
When did InSingulo AB last raise funding?
The most recent investment in InSingulo AB recorded on gritt.io was in October 2019.
What industry is InSingulo AB in?
InSingulo AB operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is InSingulo AB based?
InSingulo AB is headquartered in Mölndal, Sweden.